Downloaded from ismj.bpums.ac.ir at 20: on Friday March 22nd 2019
|
|
|
- Joella Briggs
- 5 years ago
- Views:
Transcription
1 - ( ) - -. :. ( ) :.. :... :. : // : -// : Kazem_an@modares.ac.ir
2 /..().(). ) (HLA.(). ( ) ( ). ) () ( ) ( () () () ( ). ().().().().().() (). / / / /..()..
3 / / : (LDL). SPSS) SPSS STATA. (Inc, Chicago, IL -.. / ( ) / ( ) ( ). ( ) ) ( ) ( ( ). /±/. /±/ / (BMI) 1 Kaplan-Meier 2 Log rank 3 Cox-Regression RH
4 / ). ( ). ( / ) ( ). ( /±/ /±/.. ( ). ( )... / / / /±/. /±/ ) A () ) ( RH RH RH ) B ( AB () ( RH ( ) ( RH ) RH RH ) O. ( ( /) ( /).. ( ). ( ) ( Mean ± SD /±/ Mean ± SD /±/ Mean ± SD /±/ Mean ± SD /±/ (mg/dl) /±/ /±/ /±/ /±/ (mg/dl) /±/ ±/ /±/ /±/ (mg/dl) /±/ /±/ /±/ /±/ (mg/dl) LDL ( ) ( /) ( ) / ) (
5 / /. / /. / / ) /±/ /±/ ( ( / / )... P.. / / /. /. ( /). /) (. ( ( ) ( ) ( )... / /.(P=/) ( ).
6 / /) ( /. ( ).(P=/). / / - (P=/).. ( ). (ATG) / ( /).(P=/). ATG ATG ( / ( /).(P</). ( ( ) LDL (
7 / /.( ) ( P / / / / / / / / / / / / / / / / / /. / / / / ().. /.() / ) ( ATG.. LDL LDL.( ) ( /) ( P / / / / / / / / / / / / / / / / / / / / LDL / /
8 /.().()..() (Rao).() ( )... (). ().() () () /. ()...() ( ).().
9 / / LDL.. LDL. LDL LDL. LDL...()..(-). )..() (P=/).()..().() ) (.(-) LDL
10 /. (... References: 1.Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to N Engl J Med 2000; 342: Zahedi F, Ardeshir Larijani MB. Iranian model of kidney transplantation and approaches to ethical reinforcement. Iranian J of Diabetes and Lipid disorders 2007; 7: Woo YM, Jardine AG, Clark AF, et al. Early graft function and patient survival following cadaveric renal transplantation. Kidney Int 1999; 55: Massy ZA, Guijarro C, Wiederkehr MR, et al. Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int 1996; 49: McLaren AJ, Fuggle SV, Welsh KI, et al. Chronic allograft failure in human renal transplantation: a multivariate risk factor analysis. Ann Surg 2000; 232: Floege J. Recurrent glomerulonephritis following renal transplantation: an update. Nephrol Dial Transplant 2003; 18: USRDS Annual Data Report. Renal Transplantation: Access and Outcomes. Minneapolis: 1999: Dudley C, Harden P. Assessment for renal transplantation. In: UKR Renal Association, editors. GUIDELINES CLINICAL PRACTICE. 4th ed. UK 2008.(Accessed in 3 Augest 2010 at on/assessmentforrenaltransplantation.aspx). 9.Kalble T, Lucan M, Nicita G, et al. EAU guidelines on renal transplantation. Eur Urol 2005: 47: Rezaei M, Kazemnejad A, Raeisi D, Babaei G. Survival analysis of renal transplant in Kermanshah province, Iran. Behbood 2003; 7: Ghods AJ. Renal transplantation in Iran. Nephrol Dial Transplant 2002; 17: Taghizadeh Afshari A, Makhtoomi Kh. Samadzadeh A, et al. Survival analysis of renal transplantation. 3rd conference of Iranian organ transplantation association, 2002 Sep. 3-6, Tehran, Iran. 13.Medin C, Elinder CG, Hylander B, et al. Survival of patients who have been on a waiting list for renal transplantation. Nephrol Dial Transplant 2000; 15: Cueto-Manzano AM, Rojas E, Rosales G, et al. Risk factors for long-term graft loss in kidney transplantation: experience of a Mexican single-center. Rev Invest Clin 2002; 54: Voiculescu A, Ivens K, Hetzel GR, et al. Kidney transplantation from related and unrelated living donors in a single German centre. Nephrol Dial Transplant 2003; 18: Briganti EM, Wolfe R, Russ GR, et al. Graft loss following renal transplantation in Australia: is there a centre effect?. Nephrol Dial Transplant 2002; 17: Golestan B, Hosseini-Moghaddam SM, Nafar M, et al. An Estimation of the Chronic Rejection of Kidney Transplant Using an Eternal Weibull Regression: a Historical Cohort Study. Arch Iranian Med 2009; 12: Vergoulas G. Patient And Graft Survival after Renal Transplantation. HIPPOKRATIA 2004; 8: Rao KV, Andersen RC, O'Brien TJ. Factors contributing for improved graft survival in recipients of kidney transplants. Kidney Int 1983; 24: Einollahi B, Pourfarziani V, Ahmadzad-Asl M, et al. Iranian model of renal allograft
11 / / transplantation in 3028 recipients: survival and risk factors. Transplant Proc 2007; 39: Arend SM, Mallat MJ, Westendorp RJ, et al. Patient survival after renal transplantation; more than 25 years follow-up. Nephrol Dial Transplant 1997; 12: Cosio FG, Dillon JJ, Falkenhain ME, et al. Racial differences in renal allograft survival: The role of systemic hypertension. Kidney mt 1995; 47: Meier-Kriesche HU, Vaghela M, Thambuganipalle R, et al. The effect of body mass index on long-term renal allograft survival. Transplantation 1999; 68: Ojo AO, Meier-Kriesche HU, Hanson JA, et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000; 69: Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: Ahsan N, Johnson C, Gonwa T, et al. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years. Transplantation 2001; 72: Ciancio G, Burke GW, Gaynor JJ, et al. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year. Transplantation 2004; 77: Gonwa T, Johnson C, Ahsan N, et al. Randomized trial of tacrolimus+ mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation 2003; 75: Johnson C, Ahsan N, Gonwa T, et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000; 69:
Our Experiences in Kidney Transplantation and Monitoring of Kidney Graft Outcomes
& Our Experiences in Kidney Transplantation and Monitoring of Kidney Graft Outcomes Rašić Senija¹*, Džemidžić Jasminka¹, Aganović Kenana¹, Aganović Damir², Prcić Alden² 1. Institute of Nephrology, Clinical
Acute rejection and late renal transplant failure: Risk factors and prognosis
Nephrol Dial Transplant (2004) 19 [Suppl 3]: iii38 iii42 DOI: 10.1093/ndt/gfh1013 Acute rejection and late renal transplant failure: Risk factors and prognosis Luis M. Pallardo Mateu 1, Asuncio n Sancho
The New England Journal of Medicine
The New England Journal of Medicine Copyright, 2, by the Massachusetts Medical Society VOLUME 342 M ARCH 2, 2 NUMBER 9 IMPROVED GRAFT SURVIVAL AFTER RENAL TRANSPLANTATION IN THE UNITED STATES, 1988 TO
Reduced graft function (with or without dialysis) vs immediate graft function a comparison of long-term renal allograft survival
Nephrol Dial Transplant (2006) 21: 2270 2274 doi:10.1093/ndt/gfl103 Advance Access publication 22 May 2006 Original Article Reduced graft function (with or without dialysis) vs immediate graft function
Patient Survival in Renal Allograft Failure: A Time-dependent Analysis
Nephro Urol Mon. 2014 January; 6(1): e13589. Published online 2013 October 30. DOI: 10.5812/numonthly.13589 Research Article Patient Survival in Renal Allograft Failure: A Time-dependent Analysis Moghaddameh
Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand,
Nephrol Dial Transplant (2002) 17: 2212 2219 Original Article Survival of recipients of cadaveric kidney transplants compared with those receiving dialysis treatment in Australia and New Zealand, 1991
J Am Soc Nephrol 14: , 2003
J Am Soc Nephrol 14: 208 213, 2003 Kidney Allograft and Patient Survival in Type I Diabetic Recipients of Cadaveric Kidney Alone Versus Simultaneous Pancreas/Kidney Transplants: A Multivariate Analysis
Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab
TRANSPLANTATION Recurrent Idiopathic Membranous Glomerulonephritis After Kidney Transplantation and Successful Treatment With Rituximab Khadijeh Makhdoomi, 1,2 Saeed Abkhiz, 1,2 Farahnaz Noroozinia, 1,3
Echocardiography analysis in renal transplant recipients
Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical
Modifiable factors predicting patient survival in elderly kidney transplant recipients
Kidney International, Vol. 68 (2005), pp. 345 351 Modifiable factors predicting patient survival in elderly kidney transplant recipients HÉLOISE CARDINAL,MARIE-JOSÉE HÉBERT, ELHAM RAHME, ISABELLE HOUDE,
OUT OF DATE. Choice of calcineurin inhibitors in adult renal transplantation: Effects on transplant outcomes
nep_734.fm Page 88 Friday, January 26, 2007 6:47 PM Blackwell Publishing AsiaMelbourne, AustraliaNEPNephrology1320-5358 2006 The Author; Journal compilation 2006 Asian Pacific Society of Nephrology? 200712S18897MiscellaneousCalcineurin
Mortality after kidney transplant failure: The impact of non-immunologic factors
Kidney International, Vol. 62 (2002), pp. 1875 1883 Mortality after kidney transplant failure: The impact of non-immunologic factors JOHN S. GILL, REKHA ABICHANDANI, ANNAMARIA T. KAUSZ, and BRIAN J.G.
Short-term and Long-term Survival of Kidney Allograft Cure Model Analysis
TRANSPLANTATION Short-term and Long-term Survival of Kidney Allograft Cure Model Analysis Moghaddameh Mirzaee, 1 Jalal Azmandian, 2 Hojjat Zeraati, 1 Mahmood Mahmoodi, 1 Kazem Mohammad, 1 Abbas Etminan,
Patient And Allograft Survival After Transplantation
Patient And Allograft Survival After Transplantation With A Living Donor Kidney: 14 Years Experience*. Saidi Hassan M.Med (Surg), Departments of Human Anatomy & Surgery, University of Nairobi. Email:hsaid2ke@yahoo.com
Transplantation in Australia and New Zealand
Transplantation in Australia and New Zealand Matthew D. Jose MBBS (Adel), FRACP, FASN, PhD (Monash), AFRACMA Professor of Medicine, UTAS Renal Physician, Royal Hobart Hospital Overview CKD in Australia
Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients
Original Article Kidney Res Clin Pract 37:167-173, 2018(2) pissn: 2211-9132 eissn: 2211-9140 https://doi.org/10.23876/j.krcp.2018.37.2.167 KIDNEY RESEARCH AND CLINICAL PRACTICE Long-term prognosis of BK
Date: 23 June Context and policy issues:
Title: Basiliximab for Immunosuppression During a Calcineurin Inhibitor Holiday in Renal Transplant Patients with Acute Renal Dysfunction: Guidelines for Use and a Clinical and Cost-Effectiveness Review
Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications
Original Article Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications G. R. Pourmand 1, S. Dehghani 1*, A. Saraji 1, S. Khaki 1,2, S. H. Mortazavi
MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS
MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS, PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION, AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT
CHAPTER 5 RENAL TRANSPLANTATION
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan Kin Sing Dr. Lily Mushahar Mr. Rohan Malek Dr. S. Prasad
Prevalence and Risk Factors of Recurrent Cytomegalovirus Infection in Kidney Transplant Recipients
TRANSPLANTATION Prevalence and Risk Factors of Recurrent Cytomegalovirus Infection in Kidney Transplant Recipients Mohsen Nafar, 1 Azamolsadat Roshan, 2 Fatemeh Pour-Reza-Gholi, 1 Fariba Samadian, 1 Pedram
Recurrent Diseases in the Transplant. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania
Recurrent Diseases in the Transplant Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania Case #1 21-year-old male, was on hemodialysis since September 2005 History of nephrotic
CHAPTER 14. Renal Transplantation
15th Report of the Malaysian RENAL TRANSPLANTATION CHAPTER 14 Renal Transplantation Editor: Dr. Goh Bak Leong Expert Panel: : Dato Dr. Dato Zaki Dr. Morad Zaik Morad Mohd (Chair) Zaher (Chair) Dr. Goh
CHAPTER 3 HEART AND LUNG TRANSPLANTATION. Editors: Mr. Mohamed Ezani Hj Md. Taib Dato Dr. David Chew Soon Ping
CHAPTER 3 Editors: Mr. Mohamed Ezani Hj Md. Taib Dato Dr. David Chew Soon Ping Expert Panel: Tan Sri Dato Dr. Yahya Awang (Chair) Mr. Mohamed Ezani Hj Md. Taib (Co-chair) Datin Dr. Aziah Ahmad Mahayiddin
CURRICULUM VITAE July 5, Name Chang-Kwon Oh. Date of Birth August 15, 1961
CURRICULUM VITAE July 5, 2014 Name Chang-Kwon Oh Date of Birth August 15, 1961 Present Academic & Hospital Appointment Professor, Department of Surgery Ajou University, School of Medicine Chief, Department
Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival
Original Article Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival M. S. Rezaee-Zavareh 1,2, R. Ajudani 1, M. Ramezani Binabaj 1, F. Heydari 2, B. Einollahi 2
The CARI Guidelines Caring for Australians with Renal Impairment. Assessment of donors with sub-optimal kidney function/structure GUIDELINES
Assessment of donors with sub-optimal kidney function/structure Date written: June 2004 Final submission: April 2005 GUIDELINES No recommendations possible based on Level I or II evidence SUGGESTIONS FOR
Donor and Recipient Age and the Allocation of Deceased Donor Kidneys for Transplantation
Donor and Recipient Age and the Allocation of Deceased Donor Kidneys for Transplantation July 26, 2006 Donor and Recipient Age and the Allocation of Deceased Donor Kidneys for Transplantation A paper prepared
CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr Goh Bak Leong Expert Panel: Dr Goh Bak Leong (Chair) Dato Dr (Mr) Rohan Malek Dr Wong Hin Seng Dr Fan Kin Sing Dr Rosnawati Yahya Dr S Prasad Menon Dr Tan Si
Jamalbek Ashimov, Janybek Gaibyldaev SRI of Heart Surgery and Organ Transplantation, Bishkek, Kyrgyzstan
Brief Report Types and structure of complications, and causes of mortality with different combinations of immunosuppressants in patients of undergoing organ transplantation Jamalbek Ashimov, Janybek Gaibyldaev
A clinical scoring system highly predictive of long-term kidney graft survival
http://www.kidney-international.org & 2010 International Society of Nephrology A clinical scoring system highly predictive of long-term kidney graft survival Yohann Foucher 1,2, Pascal Daguin 1,2, Ahmed
Innovation In Transplantation:
Innovation In Transplantation: Improving outcomes Thomas C. Pearson Department of Surgery Emory Transplant Center CHOA Symposium October 22, 2016 Disclosures Belatacept preclinical and clinical trial were
Diabetes Mellitus GUIDELINES UNGRADED SUGGESTIONS FOR CLINICAL CARE IMPLEMENTATION AND AUDIT BACKGROUND
Diabetes Mellitus Date written: November 2011 Author: Scott Campbell GUIDELINES a. We recommend that diabetes should not on its own preclude a patient from being considered for kidney transplantation (1D).
Advances in immunosuppression have led to marked
Impact of Acute Rejection and New-Onset Diabetes on Long-Term Transplant Graft and Patient Survival Edward H. Cole,* Olwyn Johnston, Caren L. Rose, and John S. Gill *Division of Nephrology and Multiorgan
Clinical Study Over Ten-Year Kidney Graft Survival Determinants
International Nephrology Volume 2012, Article ID 302974, 5 pages doi:10.1155/2012/302974 Clinical Study Over Ten-Year Kidney Graft Survival Determinants Anabela Malho Guedes, 1, 2 Jorge Malheiro, 1 Isabel
Mycophenolate mofetil in low-risk renal transplantation in patients receiving no cyclosporine: a single-centre experience
840 O.A. Raheem et al. Nephrol Dial Transplant (2012) 27: 840 844 doi: 10.1093/ndt/gfr263 Advance Access publication 28 May 2011 Mycophenolate mofetil in low-risk renal transplantation in patients receiving
Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.
Chronic Kidney Disease (CKD) Stages Stage 1 GFR > 90 (evidence of renal disease) Stage 2 GFR 60-89 Stage 3 GFR 30-59 Stage 4 GFR 15-29 Stage 5 GFR
Early assessment of renal resistance index after kidney transplant can help predict long-term renal function
Nephrol Dial Transplant (2006) 21: 2916 2920 doi:10.1093/ndt/gfl203 Advance Access publication 5 August 2006 Original Article Early assessment of renal resistance index after kidney transplant can help
Association of Kidney Transplantation with Survival in Patients with Long Dialysis Exposure
Article Association of Kidney Transplantation with Survival in Patients with Long Dialysis Exposure Caren Rose,* Jagbir Gill,* and John S. Gill* Abstract Background and objectives Evidence that kidney
Ten-year survival of second kidney transplants: Impact of immunologic factors and renal function at 12 months
Kidney International, Vol. 64 (2003), pp. 674 680 Ten-year survival of second kidney transplants: Impact of immunologic factors and renal function at 12 months STÉPHANIE COUPEL, MAGALI GIRAL-CLASSE, GEORGES
COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS
COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS A COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS KEVIN C. MANGE, M.D.,
Table S1. Clinical outcomes of the acceptable mismatch allocation model.
Table S1. Clinical outcomes of the acceptable mismatch allocation model. Recipient Age PRA Waiting Time (months) HLA mismatch (A/B/DR) HLAMatchmaker acceptable mismatch (years) (%) Actual Simulation Change
De novo posttransplant diabetes mellitus (PTDM) occurs
CLINICAL TRAPLANTATION Home Glucometer Monitoring Markedly Improves Diagnosis of Post Renal Transplant Diabetes Mellitus in Renal Transplant Recipients Amish Shah, 1 Gwen Kendall, 1 Richard A. Demme, 1
1980s-1990s1990s 9/24/2010. David Wojciechowski and. Mary Kennedy-Breiner. Laurie Carlson. Janine Sabatte- Caspillo
Factors Influencing Length of Stay: 1980s-1990s1990s Mail the Get Well Cards Home!! Effectively Managing Shorter Length of Stays David Wojciechowski and Higher rejection rates Longer duration of induction
Kidney transplantation 2016: current status and potential challenges
Kidney transplantation 2016: current status and potential challenges 15/12/2016 BVN-SBN : State-of-the-Art on Kidney Transplantation Patrick Peeters Ghent University Hospital, Belgium Challenges in 2016
Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study
NDT Plus (2010) 3 [Suppl 2]: ii32 ii36 doi: 10.1093/ndtplus/sfq064 Effect of long-term steroid withdrawal in renal transplant recipients: a retrospective cohort study Miguel Gonzalez-Molina 1, Miguel Angel
Outcomes of living donor kidney transplantation in diabetic patients: age and sex matched comparison with non-diabetic patients
ORIGINAL ARTICLE Korean J Intern Med 2018;33:356-366 Outcomes of living donor kidney transplantation in diabetic patients: age and sex matched comparison with non-diabetic patients Chung Hee Baek 1, Hyosang
A Lifetime of Allograft Function with Kidneys from Older Donors
A Lifetime of Allograft Function with Kidneys from Older Donors Caren Rose,* Elke Schaeffner, Ulrich Frei, Jagbir Gill,* and John S. Gill* *Division of Nephrology, University of British Columbia, Vancouver,
Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal
American Journal of Transplantation 2011; 11: 450 462 Wiley Periodicals Inc. C 2010 The Authors Journal compilation C 2010 The American Society of Transplantation and the American Society of Transplant
Københavns Universitet
university of copenhagen Københavns Universitet Survival Benefit in Renal Transplantation Despite High Comorbidity Sørensen, Vibeke Rømming; Heaf, James Goya; Wehberg, Sonja; Sørensen, Søren Schwartz Published
REACH Risk Evaluation to Achieve Cardiovascular Health
Dyslipidemia and transplantation History: An 8-year-old boy presented with generalized edema and hypertension. A renal biopsy confirmed a diagnosis of focal segmental glomerulosclerosis (FSGS). After his
Chapter 6: Transplantation
Chapter 6: Transplantation Introduction During calendar year 2012, 17,305 kidney transplants, including kidney-alone and kidney plus at least one additional organ, were performed in the United States.
CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong
CHAPTER 5 RENAL TRANSPLANTATION Editor: Dr Goh Bak Leong Expert Panel: Dr Goh Bak Leong (Chair) Dato Dr Zaki Morad Mohd Zaher Dato Dr (Mr) Rohan Malek Dr Fan Kin Sing Dr Lily Mushahar Dr Lim Soo Kun Dr
Tolerance Induction in Transplantation
Tolerance Induction in Transplantation Reza F. Saidi, MD, FACS, FICS Assistant Professor of Surgery Division of Organ Transplantation Department of Surgery University of Massachusetts Medical School Percent
RECURRENT GLOMERULONEPHRITIS RISK OF RENAL ALLOGRAFT LOSS FROM RECURRENT GLOMERULONEPHRITIS. Data Collection
RISK OF RENAL ALLOGRAFT LOSS FROM RECURRENT GLOMERULONEPHRITIS ESTHER M. BRIGANTI, M.B., B.S., M.CLIN.EPI., GRAEME R. RUSS, M.B., B.S., PH.D., JOHN J. MCNEIL, M.B., B.S., PH.D., ROBERT C. ATKINS, M.B.,
Graft survival rate of renal transplantation during a period of 10 years in Iran
Original Article Graft survival rate of renal transplantation during a period of 0 years in Iran Fatemeh Shahbazi, Mehdi Ranjbaran, Simin Karami-far, Hamid Soori 2, Hadi Jafari Manesh 3 Department of Public
Transplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital
Transplant Options for Patients: Choices and Consequences Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital BC Kidney Days October 6 th 2017 Non contributory Conflict of
Posttransplant Lymphoproliferative Disorders in Kidney Transplant Recipients An Iranian Multicenter Experience
Transplantation Posttransplant Lymphoproliferative Disorders in Kidney Transplant Recipients An Iranian Multicenter Experience Behzad Einollahi, 1 Mahboob Lessan-Pezeshki, 2 Mohammad Hossein Nourbala,
Nephrology Dialysis Transplantation
Nephrol Dial Transplant (1999) 14: 394 399 Original Article Nephrology Dialysis Transplantation Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil Rudolf P.
Objectives. Kidney Complications With Diabetes. Case 10/21/2015
Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review
Sirolimus versus Calcineurin Inhibitor-based Immunosuppressive Therapy in Kidney Transplantation A 4-year Follow-up
Transplantation Sirolimus versus Calcineurin Inhibitor-based Immunosuppressive Therapy in Kidney Transplantation A 4-year Follow-up Mohsen Nafar, 1 Behrang Alipour, 2 Pedram Ahmadpoor, 1 Fatemeh Pour-Reza-Gholi,
Renal Data from the Arab World
Saudi J Kidney Dis Transpl 2011;22(4):818-824 2011 Saudi Center for Organ Transplantation Saudi Journal of Kidney Diseases and Transplantation Renal Data from the Arab World Why does Kidney Allograft Fail?
PERSONAL USE ONLY. Renal transplantation practice in Iran and the middle east: report from Iran and a review of the literature.
Ann Transplant, 2008; 13(1): 5-14 Received: 2008.01.27 Accepted: 2008.02.22 Published: 2008.03.28 Key words Full-text PDF: Word count: 4220 Tables: 1 Figures: 3 References: 45 Author s address: Renal transplantation
Immunopathology of T cell mediated rejection
Immunopathology of T cell mediated rejection Ibrahim Batal MD Columbia University College of Physicians & Surgeons New York, NY, USA Overview Pathophysiology and grading of TCMR TCMR is still a significant
Steroid Minimization: Great Idea or Silly Move?
Steroid Minimization: Great Idea or Silly Move? Disclosures I have financial relationship(s) within the last 12 months relevant to my presentation with: Astellas Grants ** Bristol Myers Squibb Grants,
Efficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function
ArtIcle Efficacy and Safety of Thymoglobulin and Basiliximab in Kidney Transplant Patients at High Risk for Acute Rejection and Delayed Graft Function Guodong Chen, 1 Jingli Gu, 2 Jiang Qiu, 1 Changxi
Heart Transplant: State of the Art. Dr Nick Banner
Heart Transplant: State of the Art Dr Nick Banner Heart Transplantation What is achieved Current challenges Donor scarcity More complex recipients Long-term limitations Non-specific Pharmacological Immunosuppression
General Introduction. 1 general introduction 13
General Introduction In The Netherlands 13,000 patients suffer from end stage renal disease (ESRD), which left untreated inevitably results in death. Every year this number increases with approximately
Organ rejection is one of the serious
Original Article Outcomes of Late Corticosteroid Withdrawal after Renal Transplantation in Patients Exposed to Tacrolimus and/or Mycophenolate Mofetil: Meta-Analysis of Randomized Controlled Trials A.
James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant
James E. Cooper, M.D. Assistant Professor, University of Colorado at Denver Division of Renal Disease and Hypertension, Kidney and PancreasTransplant Program Has no real or apparent conflicts of interest
CHAPTER 5 RENAL TRANSPLANTATION. Editor: Rosnawati Yahya. Expert Panels: Hooi Lai Seong Ng Kok Peng Suryati Binti Yakaob Wong Hin Seng.
CHAPTER 5 Editor: Roswati Yahya Expert Panels: Hooi Lai Seong Ng Kok Peng Suryati Binti Yakaob Wong Hin Seng Contents 5. Stock and Flow of Rel Transplantation Stock and Flow Transplant Rates 5.2 Recipients
Controversies in Renal Transplantation. The Controversial Questions. Patrick M. Klem, PharmD, BCPS University of Colorado Hospital
Controversies in Renal Transplantation Patrick M. Klem, PharmD, BCPS University of Colorado Hospital The Controversial Questions Are newer immunosuppressants improving patient outcomes? Are corticosteroids
RENAL TRANSPLANTATION HAS
ORIGINAL CONTRIBUTION Arterial Hypertension and Renal Allograft Survival Kevin C. Mange, MD Borut Cizman, MD Marshall Joffe, MD, PhD Harold I. Feldman, MD, MSCE Context Several observational studies have
Receiving a Kidney Transplant in the Ninth Decade of Life
Trends Edmund in Transplant. Huang and 2011;5:121-7 Suphamai Bunnapradist: Receiving a Kidney Transplant in the Ninth Decade of Life Receiving a Kidney Transplant in the Ninth Decade of Life Edmund Huang
Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients
ESC Congress 2011 Paris 27-31 August Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients M.T. La Rovere, F. Olmetti, G.D. Pinna, R. Maestri, D. Lilleri, A. D Armini, M. Viganò,
Kidney Transplant Outcomes In Elderly Patients. Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania
Kidney Transplant Outcomes In Elderly Patients Simin Goral MD University of Pennsylvania Medical Center Philadelphia, Pennsylvania Case Discussion 70 year old Asian male, neuropsychiatrist, works full
Emerging Drug List EVEROLIMUS
Generic (Trade Name): Manufacturer: Everolimus (Certican ) Novartis Pharmaceuticals NO. 57 MAY 2004 Indication: Current Regulatory Status: Description: Current Treatment: Cost: Evidence: For use with cyclosporine
CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Rosnawati Yahya
CHAPTER 5 Editor: Dr Rosnawati Yahya Expert Panels: Dr Rosnawati Yahya Dr Ng Kok Peng Dr Suryati Binti Yakaob Dr Mohd Zaimi Abd Wahab Dr Yee Seow Ying Dr Wong Hin Seng Contents 5. Stock and Flow of Renal
Why Do We Need New Immunosuppressive Agents
Why Do We Need New Immunosuppressive Agents 1 Reducing acute rejection rates has not transplanted into better long-term graft survival Incidence of early acute rejection episodes by era Relative risk for
Intruduction PSI MODE OF ACTION AND PHARMACOKINETICS
Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation Andreas Zuckermann, MD et al. Department of Cardio-Thoracic Surgery, Medical University
Obesity in renal transplantation
Obesity in renal transplantation Date written: November 2011 Author: Christine Russell GUIDELINES a. We recommend that obesity should not on its own preclude a patient from being considered for kidney
Renal Transplant Registry Report 2008
Renal Transplant Registry Report 28 Contents:. Introduction Page 2. Summary of transplant activity 27-28 Page 2 3. Graft and Patient Survival analysis 989-28 Page 3 4. Acute rejection 989-28 Page 24. Comparison
Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients
Wiley Periodicals Inc. C Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons Quantification of the Early Risk of Death in Elderly Kidney Transplant Recipients
Overview of New Approaches to Immunosuppression in Renal Transplantation
Overview of New Approaches to Immunosuppression in Renal Transplantation Ron Shapiro, M.D. Professor of Surgery Surgical Director, Kidney/Pancreas Transplant Program Recanati/Miller Transplantation Institute
Le migliori strategie immunosoppressive per il paziente con re-trapianto Prof. Maurizio Salvadori FIRENZE
Le migliori strategie immunosoppressive per il paziente con re-trapianto Prof. Maurizio Salvadori FIRENZE Best Therapy for Kidney Re- Transplantation? PREVENTION!!!! Registries CTS OPTN UNOS USRDS SRTR
Renal transplantation
NEPHROLOGY 2008; 13, S37 S43 doi:10.1111/j.1440-1797.2008.00996.x Renal transplantation Date written: November 2006 Final submission: July 2007 Author: Nigel Toussaint GUIDELINES No recommendations possible
The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantation
Clin Transplant 2012: 26: 403 410 DOI: 10.1111/j.1399-0012.2011.01519.x ª 2011 John Wiley & Sons A/S. The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas
The most common causes of kidney transplant failure include
A Comparison of the Effects of C2-Cyclosporine and C0-Tacrolimus on Renal Function and Cardiovascular Risk Factors in Kidney Transplant Recipients S. Joseph Kim, 1 G. V. Ramesh Prasad, 1,2 Michael Huang,
Donor Scoring System for Cadaveric Renal Transplantation
American Journal of Transplantation 2001; 1: 162 170 Copyright C Munksgaard 2001 Munksgaard International Publishers ISSN 1600-6135 Donor Scoring System for Cadaveric Renal Transplantation Scott L. Nyberg
Mortality After Kidney Transplantation: A Comparison Between the United States and Canada
American Journal of Transplantation 2006; 6: 109 114 Blackwell Munksgaard C 2005 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/j.1600-6143.2005.01141.x
Increased Early Rejection Rate after Conversion from Tacrolimus in Kidney and Pancreas Transplantation
Increased Early Rejection Rate after Conversion from Tacrolimus in Kidney and Pancreas Transplantation Gary W Barone 1, Beverley L Ketel 1, Sameh R Abul-Ezz 2, Meredith L Lightfoot 1 1 Department of Surgery
Chui, AKK; Lo, ACY; Chan, DTM; Tam, PC; Ho, KK; Hawkins, BR; Wong, J; Cheng, IKP
Title Author(s) Comparison of the outcome of living related donor and cadaveric renal transplantation in Queen Mary Hospital - a single centre experience Chui, AKK; Lo, ACY; Chan, DTM; Tam, PC; Ho, KK;
Single-dose thymoglobulin induction in living-donor renal transplantation
Ann Transplant, 2; (2): 5-58 Original Paper Received: 2.2.5 Accepted: 2.3.4 Published: 2..3 Authors Contribution: A Study Design B Data Collection C Statistical Analysis D Data Interpretation E Manuscript
Supplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Lefaucheur C, Loupy A, Vernerey D, et al. Antibody-mediated
Downloaded from:
Li, B; Cairns, JA; Robb, ML; Johnson, RJ; Watson, CJ; Forsythe, JL; Oniscu, GC; Ravanan, R; Dudley, C; Roderick, P; Metcalfe, W; Tomson, CR; Bradley, JA (2016) Predicting patient survival after deceased
Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys?
Nephrol Dial Transplant (2017) 32: 1934 1938 doi: 10.1093/ndt/gfx257 Advance Access publication 21 August 2017 Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality
Pharmacology notes Interleukin-2 receptor-blocking monoclonal antibodies: evaluation of 2 new agents
BUMC Proceedings 1999;12:110-112 Pharmacology notes Interleukin-2 receptor-blocking monoclonal antibodies: evaluation of 2 new agents CHERYLE GURK-TURNER, RPH Department of Pharmacy Services, BUMC wo mouse/human
GUIDELINES ON RENAL TRANSPLANTATION
46 GUIDELINES ON RENAL TRANSPLANTATION T. Kälbe (chairman), M. Lucan, G. Nicita, R. Sells, F.J. Burgos Revilla, M. Wiesel Introduction The number of patients registered as starting end-stage renal disease
Chronic Kidney Disease & Transplantation. Paediatrics : 2004 FRACP
Chronic Kidney Disease & Transplantation Paediatrics : 2004 FRACP ANZDATA Registry Mode of First Treatment - Paediatric 14 12 10 8 6 4 2 0 0-4 y 5-9 y 10-14 y 15-19 y Hospital CAPD Hospital HD Hospital